{{Rsnum
|rsid=2306168
|Gene=SLCO2B1
|Chromosome=11
|position=75196537
|Orientation=plus
|GMAF=0.1763
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=SLCO2B1
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 91.1 | 8.9 | 0.0
| HCB | 57.9 | 38.3 | 3.8
| JPT | 33.9 | 50.9 | 15.2
| YRI | 34.2 | 47.9 | 17.8
| ASW | 50.9 | 35.1 | 14.0
| CHB | 57.9 | 38.3 | 3.8
| CHD | 61.5 | 30.3 | 8.3
| GIH | 82.8 | 16.2 | 1.0
| LWK | 44.4 | 44.4 | 11.1
| MEX | 75.0 | 23.2 | 1.8
| MKK | 47.4 | 43.6 | 9.0
| TSI | 94.1 | 5.9 | 0.0
| HapMapRevision=28
}}{{PharmGKB
|RSID=rs2306168
|Name_s=SLCO2B1:C1457T, SLCO2B1:Ser486Phe
|Gene_s=SLCO2B1
|Feature=Exon/NonSyn
|Evidence=PubMed ID:19151602
|Annotation=In an 80-patient study, this variant was not associated with plasma concentrations of montelukast or with response to treatment with montelukast.
|Drugs=montelukast
|Drug Classes=
|Diseases=Asthma
|Curation Level=Curated
|PharmGKB Accession ID=PA162928869
}}

{{GET Evidence
|gene=SLCO2B1
|aa_change=Ser486Phe
|aa_change_short=S486F
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs2306168
|overall_frequency_n=1409
|overall_frequency_d=10758
|overall_frequency=0.130972
|n_genomes=19
|n_genomes_annotated=0
|n_haplomes=23
|n_articles=0
|n_articles_annotated=0
|nblosum100=5
|autoscore=0
|webscore=N
}}

{{PMID Auto
|PMID=23666051
|Title=SLCO2B1 genetic polymorphisms in a Korean population: pyrosequencing analyses and comprehensive comparison with other populations.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Illumina Human 1M}}